BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Nagasaki University & NEC OncoImmunity Partner for Universal Vaccines Against Tropical Diseases

The collaboration between NOI and Nagasaki University aims to harness the power of advanced AI to optimize vaccine designs to be universally and broadly pr...

August 21, 2023 | News

Breakthrough 'eAir' Aero-Elastic Pressure Sensor from NUS Set to Revolutionize Medical Implants and Surgeries

The eAir sensor promises increased precision and reliability across medical applications. It can potentially transform laparoscopic surgeries by enabling t...

August 19, 2023 | News

Neurophth Begins Phase I/II Trial for Second Gene Therapy with First Patient Dosed

Neurophth is conducting a Phase I/II, multi-region, multi-center, single-arm, open-labeled, dose-finding study aimed at evaluating the safety, tole...

August 18, 2023 | News

Minghui Pharma Enrolls First Patient in Phase 3 Study for MH004 Cream in Atopic Dermatitis

The phase 3 clinical trial aims to evaluate the safety and efficacy of the investigational topical cream in a larger patient population. Leveraging the con...

August 18, 2023 | News

Daewoong Pharmaceutical Introduces 'Fexuprazan' with Global Export to the Philippines

Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that 'Fuxuprazan' is officially launched in the Philippines o...

August 17, 2023 | News

Infinitus & Jiangnan University Create Center for Herbal Medicine-Probiotic Combo

Lam Yu, CEO of Infinitus Global and Vice Chairman of Infinitus (China), expressed his enthusiasm in his speech, "Infinitus has been deeply involved in th...

August 16, 2023 | News

OnCusp Therapeutics Gets FDA Nod for Phase 1 Trial of CUSP06 in Ovarian & Solid Tumors

"We are delighted to announce the IND approval for our flagship program, CUSP06, which has demonstrated excellent anti-tumor efficacy across diverse in&nbs...

August 16, 2023 | News

Thermo Fisher Scientific Completes Acquisition of CorEvitas

Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Sh...

August 15, 2023 | News

Kelun-Biotech's Phase III Trial of SKB264 Meets Endpoint in Advanced TNBC

Kelun-Biotech recently held an Independent Data Monitoring Committee (IDMC) meeting to review the interim analysis data of the Phase III clinical trial of ...

August 15, 2023 | News

Asieris Reports Successful Phase III Bridging Trial for Hexvix® in Bladder Cancer Diagnosis

The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...

August 14, 2023 | News

Aichi Cancer Center & NEC Advance Lung Cancer Antigen Identification

Aichi Cancer Center and NEC developed a method for efficiently identifying lung cancer antigens (oncology marks) and antigen-specific T cells by comb...

August 10, 2023 | News

Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing

Lonza adds new Nebula® Absorbance Reader to its portfolio of Lonza-developed and optimized microplate readers for streamlined endotoxin and pyrogen t...

August 09, 2023 | News

Agilent Inaugurates First Integrated Biology Center at Monash University in Malaysia

Agilent Technologies Inc. (NYSE: A) announced the opening of a new full-scale Integrated Biology Center located at Monash University in Ma...

August 08, 2023 | News

DualityBio, BioNTech Expand Partnership for Solid Tumor Antibody-Drug Conjugate

The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...

August 08, 2023 | News

Stay Connected